The case for postmenopausal hormone therapy.
作者信息
Speroff L
机构信息
Oregon Health Sciences University School of Medicine, Portland, Oregon, USA.
出版信息
Hosp Pract (1995). 1996 Feb 15;31(2):75-89.
PMID:8592021
Abstract
Because randomized trials of the impact of hormone therapy on women's health are lacking, clinicians can only point out the benefits established in observational studies, discuss the potential risks, and allow each patient to decide for herself. Informed decision making is time-consuming, however. Ample educational materials and a counselor may facilitate the process.
摘要
相似文献
1
The case for postmenopausal hormone therapy.
Hosp Pract (1995). 1996 Feb 15;31(2):75-89.
2
Hormone replacement therapy and the menopause. Australian Menopause Society.
Med J Aust. 1991 Jul 1;155(1):43-4.
3
Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rep Med Guidel Outcomes Res. 2002 Aug 9;13(15):5-7.
4
[Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
Dtsch Med Wochenschr. 1999 Oct 22;124(42):1245-8. doi: 10.1055/s-2007-1024528.
5
Postmenopausal hormone replacement therapy: does the progestin make a difference?
J S C Med Assoc. 2002 Feb;98(1):12-9.
6
[The benefits and risks of hormonal replacement therapy--an update].
Gynakol Geburtshilfliche Rundsch. 2006;46(4):166-73. doi: 10.1159/000095725.
7
Hormone replacement therapy: estrogen after menopause.
Pharmacotherapy. 1996 May-Jun;16(3):366-75.
8
Health risks after cessation of postmenopausal hormone therapy.
Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228.
9
Deciding on hormone replacement therapy.
Am J Nurs. 1995 Aug;95(8):57-9.
10
A comparative review of the risks and benefits of hormone replacement therapy regimens.
Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. doi: 10.1016/j.ajog.2003.09.033.
Zotero 插件